Childhood Malignant Neoplasm — Trials

Childhood Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 263
Recruiting: 158
Ph III recruiting: 9
Growth YoY: −7.4%
Industry share: 8%
Top sponsor: St. Jude Children's Research Hospital
Termination share: 19.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (92)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06620302	Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma	suspended	Phase 1 / Phase 2	81	Children's Oncology GroupNETWORK	1	Aug 24, 2026	clinicaltrials
NCT04539366	Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial	suspended	Phase 1	73	National Cancer Institute (NCI)NIH